Invention Grant
- Patent Title: Method for treating arthritis using IK factor or nucleic acid encoding IK factor
-
Application No.: US14784614Application Date: 2014-04-16
-
Publication No.: US09737588B2Publication Date: 2017-08-22
- Inventor: Jae-Hwan Nam , Hye-Lim Park , Dong-Hee Lee
- Applicant: CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION , CELLINBIO CO., LTD
- Applicant Address: KR Seoul KR Seoul
- Assignee: CELLINBIO CO., LTD,CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
- Current Assignee: CELLINBIO CO., LTD,CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
- Current Assignee Address: KR Seoul KR Seoul
- Agency: Faegre Baker Daniels LLP
- Priority: KR10-2013-0041771 20130416; KR10-2014-0038809 20140401
- International Application: PCT/KR2014/003282 WO 20140416
- International Announcement: WO2014/171721 WO 20141023
- Main IPC: A61K38/19
- IPC: A61K38/19 ; A61K48/00 ; A01K67/027 ; A61K38/21

Abstract:
The present invention relates to a pharmaceutical composition for treating and/or preventing arthritis, which comprising, as an active ingredient, a gene delivery vehicle into which an IK factor or a fragment thereof, or a nucleic acid encoding thereof is inserted. IK factor or the fragment thereof, and the nucleic acid encoding thereof, which are the active ingredient of the pharmaceutical composition according to the present invention, are derived from an organism and therefore, show no side effects in administered into a subject for a long time. Accordingly, they ensures safety and are expected to effectively treat arthritis by being involved in the upstream mechanism for suppressing arthritis.
Public/Granted literature
- US20160058836A1 IK FACTOR AND PHARMACEUTICAL USE OF NUCLEIC ACID ENCODING IK FACTOR Public/Granted day:2016-03-03
Information query
IPC分类: